You are here: Industry Insights > Catalent

News List

Catalent Appoints Open Innovation, Biologics, Cell and Gene Therapy VP contractpharma
November 20, 2020
Behzad Mahdavi brings more than 20 years of experience in developing and implementing growth strategies in the biopharmaceutical industries.
Catalent completes acquisition of Bone Therapeutics’ cell therapy manufacturing subsidiary SCTS expresspharma
November 17, 2020
Catalent Pharma Solutions has completed the acquisition of Bone Therapeutics’ manufacturing subsidiary, Skeletal Cell Therapy Support SA (SCTS), announced on 29 October 2020.
Taysha Gene Therapies Partners with Catalent contractpharma
November 06, 2020
Taysha Gene Therapies Inc., a patient-centric gene therapy company focused on developing and commercializing adeno-associated virus (AAV)-based gene therapies for the treatment of monogenic diseases of the central nervous system, and Catalent ...
Catalent to Acquire Bone Therapeutics’ Cell Therapy Mfg. Facility contractpharma
October 30, 2020
Catalent has signed an agreement with Bone Therapeutics to acquire its cell therapy manufacturing subsidiary, Skeletal Cell Therapy Support SA (SCTS), including all of its assets located in Gosselies, Belgium.
Stevanato Group, Catalent Partner to Expedite Equipment Installation contractpharma
October 29, 2020
Stevanato’s high-speed visual inspection machines will support biologic and vaccine programs at Catalent manufacturing sites in U.S. and Italy.
Catalent, BrainStorm Enter ALS Drug Manufacturing Pact contractpharma
October 23, 2020
Catalent will undertake the transfer of the manufacturing process to, and provide future cGMP clinical supply of NurOwn from its Houston facility.
Catalent Provides Mfg. Support for Nocion Program contractpharma
October 09, 2020
Manufactures clinical-scale batches of blow-fill-seal nebulizer ampules to treat cough in patients with COVID-19.
Catalent Acquires New Biologics Facility contractpharma
September 27, 2020
Catalent, a global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, has acquired a new manufacturing facility in Bloomington, IN ...
T-knife, Catalent Sign Tech Transfer and Mfg. Pact for Cell Therapy contractpharma
September 22, 2020
Catalent to provide technology transfer and cGMP clinical manufacture of T-knife’s T1367 T-cell receptor program at its site in Gosselies, Belgium.
Catalent Invests $130M in Harmans Gene Therapy Campus contractpharma
September 18, 2020
To add five additional Phase 3 through commercial-scale manufacturing suites to support growing market demand.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page